|Place of Origin:||China|
|Model Number:||LORCASERIN HYDROCHLORIDE|
|Minimum Order Quantity:||1KG|
|Packaging Details:||Aluminum foil bag|
|Payment Terms:||L/C, D/A, D/P, T/T, Western Union, MoneyGram，Alibaba Assurance Order|
|Einecs No.:||N/A||Appearance:||White Crystalline Powder|
Hcl Lorcaserin Hydrochloride Powder,
Lorcaserin Hydrochloride Powder Cas 846589-98-8,
Cas 846589-98-8 Weight Losing Raw Material
CAS: 846589-98-8 WEIGHT LOSING RAW MATERIAL 99% LORCASERIN HCL LORCASERIN HYDROCHLORIDE POWDER
The Introductction of LORCASERIN HYDROCHLORIDE(LORCASERIN)
Lorcaserin hydrochloride(lorcaserin) is a novel drug for the treatment of obesity and is an orally effective selective 5-hydroxytryptamine 2C receptor agonist. lorcaserinhydrochloride (BelviqTM) was successfully developed by Arena, Inc. and approved for marketing by the FDA on June 27, 2012 for It is used as an adjunctive treatment for obese or overweight adults with at least one weight-related complication based on a low-calorie diet and exercise. Clinical studies have shown that the drug is effective in reducing body weight and improving obesity-related metabolic markers in obese and overweight patients, and is well tolerated. With a 100-fold higher affinity for 5-HT2c than 5-HT2B (risk of heart valve disease) and a better safety profile, lorcaserin hydrochloride(lorcaserin) was the first weight loss drug approved by the FDA after 1999. The average weight loss for one year of treatment with crocaserin ranged from 3% to 3.7%.
Lorcaserin hydrochloride(lorcaserin) is well tolerated and safe. The most common adverse effects of cloxacillin in non-diabetic patients include headache dizziness fatigue nausea dry mouth and constipation. The most common adverse reactions to the use of this product in diabetic patients include hypoglycemia headache back pain cough and fatigue.
Studies have found similar rates of serious adverse reactions with lorcaserin hydrochloride(lorcaserin) and placebo, and lorcaserin hydrochloride(lorcaserin) did not increase the incidence of heart valve disease. The incidence of depression and depressed mood after crocaserin treatment was low, and the study showed that lorcaserin hydrochloride(lorcaserin) 10mgbid, 10mgqd and placebo resulted in 1.9%, 1.1% and 1.8% of depression, 0.6%, 0.9% and 0.9% of depressed mood, and 0.9%, 0.6% and 0.7% of suicidal thoughts, respectively. 0.6% and 0.7%, respectively. This product is a pregnancy drug with Class X status and is contraindicated in women during pregnancy; whether this product is secreted through breast milk is unknown and the use of this drug in nursing women should be weighed against the benefits; this product is not recommended for use in children.